AMEX · Financial Statements

Stereotaxis, Inc. (STXS) Revenue, Earnings & Financial Statements

$0.88 AMEX: STXS Market Cap $88.39M

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Stereotaxis, Inc. most recently reported annual revenue of $32.0M, a net loss of $22.0M. Revenue grew at an average annual rate of 3.5% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Stereotaxis, Inc.: Revenue rose from $32.0M in 2016 to $32.0M in 2025, a change of +0.0% over 9 years; net profit was positive in 0 of 10 reported years; operating margin moved from -20.0% to -68.3%, a shift of -48.3 percentage points; the most recent year shows a net loss of $22.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$32.0M$31.0M$29.0M$29.0M$27.0M$35.0M$28.0M$27.0M$27.0M$32.0M
Operating Expenses$39.0M$37.0M$32.0M$34.0M$33.0M$48.0M$47.0M$49.0M$52.0M$54.0M
Operating Profit−$6.0M−$6.0M−$2.0M−$5.0M−$7.0M−$13.0M−$19.0M−$22.0M−$25.0M−$22.0M
Operating Margin-20.0%-19.0%-8.4%-16.7%-25.2%-36.8%-66.7%-81.6%-91.9%-68.3%
Other Income$1.0M$0$3.0M$0$0$2.0M$0$1.0M$1.0M$0
Interest$2.0M$0$0$0$0$0$0$0$0$0
Depreciation$1.0M$1.0M$1.0M$0$0$0$0$1.0M$1.0M$2.0M
Profit Before Tax−$5.0M−$6.0M$0−$5.0M−$7.0M−$11.0M−$18.0M−$21.0M−$24.0M−$22.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit−$5.0M−$6.0M$0−$5.0M−$7.0M−$11.0M−$18.0M−$21.0M−$24.0M−$22.0M
EPS−$0.24−$0.26$0.00−$0.07−$0.11−$0.16−$0.26−$0.27−$0.30−$0.25

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$5.0M$7.0M$5.0M$9.0M$6.0M$7.0M$9.0M$7.0M$9.0M$6.0M$8.0M$9.0M
Operating Expenses$10.0M$12.0M$11.0M$16.0M$14.0M$13.0M$13.0M$14.0M$14.0M$11.0M$12.0M$15.0M
Operating Profit−$5.0M−$5.0M−$6.0M−$6.0M−$8.0M−$6.0M−$4.0M−$7.0M−$6.0M−$5.0M−$5.0M−$6.0M
Operating Margin-116.2%-69.0%-133.7%-69.0%-120.3%-79.3%-45.2%-87.8%-65.4%-82.4%-59.6%-72.5%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax−$5.0M−$5.0M−$6.0M−$6.0M−$8.0M−$6.0M−$4.0M−$6.0M−$6.0M−$6.0M−$4.0M−$6.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit−$5.0M−$5.0M−$6.0M−$6.0M−$8.0M−$6.0M−$4.0M−$6.0M−$6.0M−$6.0M−$4.0M−$6.0M
EPS−$0.06−$0.06−$0.07−$0.08−$0.09−$0.07−$0.05−$0.07−$0.06−$0.06−$0.05−$0.07

Over the 10 years reported for Stereotaxis, Inc., cash stood at $13.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.55 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$21.0M$11.0M$19.0M$44.0M$55.0M$61.0M$53.0M$42.0M$47.0M$52.0M
Current Assets$19.0M$10.0M$18.0M$39.0M$53.0M$51.0M$43.0M$33.0M$26.0M$34.0M
Cash$9.0M$4.0M$11.0M$30.0M$44.0M$39.0M$9.0M$20.0M$12.0M$13.0M
Inventory$5.0M$1.0M$1.0M$2.0M$3.0M$4.0M$8.0M$8.0M$8.0M$10.0M
Receivables$5.0M$4.0M$5.0M$5.0M$4.0M$5.0M$5.0M$4.0M$4.0M$10.0M
Fixed Assets$1.0M$1.0M$0$5.0M$2.0M$8.0M$9.0M$8.0M$9.0M$8.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$0$20.0M$0$0$0
Other Assets$0$0$0$0$0$0$0$0$4.0M$4.0M
Total Liabilities$36.0M$31.0M$11.0M$15.0M$15.0M$22.0M$21.0M$20.0M$35.0M$34.0M
Current Liabilities$36.0M$30.0M$10.0M$12.0M$14.0M$13.0M$14.0M$13.0M$22.0M$22.0M
Borrowings$0$0$0$4.0M$4.0M$6.0M$6.0M$5.0M$6.0M$5.0M
Other Liabilities$36.0M$31.0M$11.0M$11.0M$11.0M$15.0M$16.0M$14.0M$29.0M$28.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves−$16.0M−$21.0M$7.0M$29.0M$40.0M$39.0M$32.0M$22.0M$11.0M$19.0M

For Stereotaxis, Inc., operating cash flow was positive in 0 of 10 reported years; free cash flow in the latest year was negative at $14.0M; free cash flow was positive in 0 of 10 years.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow−$7.0M−$5.0M−$3.0M−$5.0M−$4.0M−$3.0M−$8.0M−$9.0M−$8.0M−$14.0M
Investing Cash Flow−$1.0M$0−$1.0M$0$0−$3.0M−$24.0M$19.0M$0$0
Financing Cash Flow$0$0$10.0M$0$0$0$0$0$0$0
Net Cash Flow$3.0M−$5.0M$7.0M$19.0M$14.0M−$4.0M−$30.0M$11.0M−$8.0M$1.0M
Free Cash Flow−$7.0M−$5.0M−$3.0M−$5.0M−$4.0M−$4.0M−$11.0M−$10.0M−$9.0M−$14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.23
EV / EBITDA-4.19
FCF Yield-18.35%
Quick Ratio0.67
Interest Coverage-497.02
Return 1Y-58.49%
Return 3Y-43.59%
Return 5Y-86.48%

Stereotaxis, Inc. (STXS) financials — frequently asked questions

What is Stereotaxis, Inc.'s annual revenue?

Stereotaxis, Inc. (STXS) reported annual revenue of $32.0M in its most recent fiscal year.

What is Stereotaxis, Inc.'s net profit?

Stereotaxis, Inc. (STXS) reported a net loss of $22.0M in its most recent fiscal year.

What is STXS EV/EBITDA?

Stereotaxis, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -4.19. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Medical - Instruments & Supplies stocks

BDX revenue $19.5BMDLN stockWST revenue $3.1BSOLV revenue $8.3BBAX revenue $11.2BCOO revenue $4.1BRGEN revenue $738.0MAVTR revenue $6.6BATR revenue $3.8BBLCO revenue $5.1BAll Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
STXS Overview STXS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.